Latest News

Contract-based revenue streams are offsetting weakness in property sales, a shift that reframes how CBRE earns through market cycles.

Wall Street is missing Nike's transformation.

Broadcom's 36% net margins crush Dell's 5%, but Dell trades at a fraction of the price, a classic growth-versus-value showdown in AI infrastructure.

Airbnb boasts a 20% net margin and fortress balance sheet, while Chewy's pharmacy expansion offers growth but carries regulatory complexity.

The fuel cell maker now expects its sales to more than double this year. Is the lower share price an opening?

One company serves corporations in a cyclical, increasingly competitive business environment. The other serves consumers who are loyal regardless of the economic backdrop.

Abbott's $7.4B free cash flow and 0.3x debt load contrast sharply with UnitedHealth's $16.1B free cash flow but higher leverage and government policy risk.

Margin expansion from eliminated overhead and software-bundled orders are compounding cash generation, fueling sharper capital allocation choices.

Enthusiasm for the company's next earnings report is only one catalyst for this AI stock's rise.

Insider buying signals confidence after stock declined 47% over 12 months. Conifer now holds ~1.5 million shares, representing 13% of the company.

The average monthly check covers far less of typical senior expenses than most retirees expect.

Retirees shouldn't turn a blind eye to the elephants in the room.

BUDA (NYSEAMERICAN:BUDA) outlined its strategy to expand distribution of its “Ultra Fresh” juice and beverage products, emphasizing a wholesale model, a refrigerated supply chain and plans to add production capacity in the eastern and western United States. During a company presentation, management

Your choice will have a huge effect on your retirement healthcare costs next year.

Data privacy commitments are becoming a structural competitive moat as enterprise clients embrace AI automation.

IonQ is the most famous quantum stock on the market, and it is worth $12.5 billion. One satellite imaging company and one nuclear start-up could both pass it by 2031.

Wizards of the Coast is powering growth and profits for Hasbro.

Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience.

The privacy coin has been a standout performer in a tough crypto market.

Booking's 20% net margin and $9.1B free cash flow contrast sharply with Home Depot's leverage and housing-market sensitivity.

This tech leader is going all in on AI.

Rocket Lab's Neutron delay has the stock sliding, but Redwire is building a broader space and defense business. Profits remain its real test.

The dividend is not only huge -- it's also growing.

The program will have a handful of different thresholds next year.